Vrisha Pharmaceuticals Private Limited - Due diligence report

A 360° intelligence report on Vrisha Pharmaceuticals Private Limited: trust score, financial health, credit view, compliance, directors, gro…

2005-10-18 Navi Mumbai, Maharashtra Active Unlisted Active Compliant
Share
Connect MCP
VP Vrisha Pharmaceuticals Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Vrisha Pharmaceuticals Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
84/100
Trust Score
Low Risk

Vrisha Pharmaceuticals Private Limited is assessed as Low Risk with a Trust Score of 84/100. Vrisha Pharmaceuticals Private Limited is an active private limited indian non-government company incorporated in 2005, operating in the Pharma sector. Reported revenue has declined across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.

Report generated on 12 Aug 2026 from the latest processed filings. Vrisha Pharmaceuticals Private Limited snapshot & full profile →

Financial Health › Good
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
84/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
90/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
60/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
50/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
50/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 50/100 Moderate
  • Liabilities ≈ 38% EBITDA - stretched.
  • Moderate gearing (D/E 1.42).

Charges position: 2 open (2.96 cr) · 3 satisfied (3.67 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Others1 48.0 cr
Icici Bank Limited1 48.0 cr
Standard Chartered Bank1 48.0 cr
Axis Bank Limited1 48.0 cr
First Blue Home Finance Limited1 48.0 cr
Compliance Score: 90/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • 1 auditor resignation(s) filed - latest: HEMANT SHETTY & CO on 2015-09-30.
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
JAGDISH MADHUKAR CHAUDHARI 01234567 Director 01/04/2018 6 yrs Approved
SAJID SYED ASFI 01234567 Director 01/04/2018 6 yrs Approved
RAJENDRA ANANT APANDKAR 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2021)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2022 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 50 · Distress 90
Growth signals & trust indicators
Latest year revenue grew 2.1x.
Operating for 20+ years.
Active GST registration(s).
Distress signals & risk flags
2 open charge(s) registered - assets are encumbered.
1 auditor resignation(s) on record - review the stated reasons.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence88/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • No distress signals on file.
  • Financial filings available for verification.
Banker assessment63/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 2 open charge(s) of 2.96 cr already registered.
  • Compliance record supports lending.
Investor view62/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 1 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
17 Dec 2021
Director appointed
JAGDISH MADHUKAR CHAUDHARI (Additional Director)
03 Jun 2019
Director ceased
JAGDISH MADHUKAR CHAUDHARI
28 Sep 2018
Director ceased
SAJID SYED ASFI
Director ceased
RAJENDRA ANANT APANDKAR
20 May 2018
Director appointed
SAJID SYED ASFI (Director)
13 Dec 2017
Director appointed
RAJENDRA ANANT APANDKAR (Director)
30 Sep 2016
Director ceased
DADA SHANKAR YADAV
22 Jul 2016
Charge created
Others - 2.01 cr
02 May 2016
Charge satisfied
Standard Chartered Bank
01 Dec 2015
Charge satisfied
Icici Bank Limited
02 Nov 2015
Director ceased
SEEMA JAGDISH CHAUDHARI
31 Oct 2013
Charge satisfied
First Blue Home Finance Limited
23 Sep 2013
Charge created
Icici Bank Limited - 1.77 cr
10

Key Observations

Auto-generated from the data above
Revenue declined 24% over the last 4 financial year(s).
Net profit margin moved from 0.86 to 61%.
Debt-to-equity stands at 38% - manageable leverage.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
3 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
Promoters hold a dominant controlling stake as per the FY 2022 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Bien Artium Natural Science Pvt Ltd U27109WB1947PTC015710 Kolkata, West Bengal, India
Celestial Genesis Engineering Services Private Limited U31909RJ2009PTC028748 Jaipur, Rajasthan, India
Panexus Acipl Chemicals Private Limited U24100MH2008PTC182237 Mumbai, Maharashtra, India
Jute Balers' Association U17232WB1918GAP002995 Kolkata, West Bengal, India
Expert Tubewell Engineers U45209PB2003PTC026371 Punjab, Punjab, India
Locus Exim Private Limited U51909DL1996PTC080148 New Delhi, Delhi, India
Dipru Paints Private Limited U36998GJ2018PTC102260 Ahmedabad, Gujarat, India
Prateek Fiscal Services Pvt Ltd U65993WB1989PTC047333 North 24 Pgs, West Bengal, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Vrisha Pharmaceuticals Private Limited before audits and certifications: compliance score 90/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Vrisha Pharmaceuticals Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 50/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 50/100, margin trends, ownership structure and peer set for Vrisha Pharmaceuticals Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 84/100, distress signals and MSME payment-delay disclosures - know whether Vrisha Pharmaceuticals Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Vrisha Pharmaceuticals Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Vrisha Pharmaceuticals Private Limited an active company?

Vrisha Pharmaceuticals Private Limited has MCA status “Active” with a compliance score of 90/100 (Low Risk).

Is Vrisha Pharmaceuticals Private Limited financially healthy?

Vrisha Pharmaceuticals Private Limited has a Financial Health Score of 60/100 (Moderate) based on its filed financial statements.

Should I do business with Vrisha Pharmaceuticals Private Limited?

Its overall Trust Score is 84/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Vrisha Pharmaceuticals Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 3 active director(s) are on record.

Does Vrisha Pharmaceuticals Private Limited have loans or charges against its assets?

2 open charge(s) are registered against its assets, and 3 earlier charge(s) stand satisfied.

Is Vrisha Pharmaceuticals Private Limited up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 90/100 (Low Risk).

Is it risky to lend to Vrisha Pharmaceuticals Private Limited?

Its Credit Risk Score is 50/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.